{"name":"Scioderm, Inc.","slug":"scioderm-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"Vehicle (SD-101 0%)","genericName":"Vehicle (SD-101 0%)","slug":"vehicle-sd-101-0","indication":"Other","status":"phase_3"},{"name":"Placebo (SD-101-0.0) cream","genericName":"Placebo (SD-101-0.0) cream","slug":"placebo-sd-101-0-0-cream","indication":"Control comparator in phase 3 clinical trials (specific indication unknown)","status":"phase_3"}]},{"name":"Dermatology","slug":"dermatology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"SD-101 Dermal Cream (6%)","genericName":"SD-101 Dermal Cream (6%)","slug":"sd-101-dermal-cream-6","indication":"Dermatological indication (specific indication not publicly disclosed)","status":"phase_3"}]}],"pipeline":[{"name":"Vehicle (SD-101 0%)","genericName":"Vehicle (SD-101 0%)","slug":"vehicle-sd-101-0","phase":"phase_3","mechanism":"Vehicle serves as a control in clinical trials.","indications":[],"catalyst":""},{"name":"Placebo (SD-101-0.0) cream","genericName":"Placebo (SD-101-0.0) cream","slug":"placebo-sd-101-0-0-cream","phase":"phase_3","mechanism":"Placebo cream contains no active pharmaceutical ingredient and produces therapeutic effects solely through the placebo effect.","indications":["Control comparator in phase 3 clinical trials (specific indication unknown)"],"catalyst":""},{"name":"SD-101 Dermal Cream (6%)","genericName":"SD-101 Dermal Cream (6%)","slug":"sd-101-dermal-cream-6","phase":"phase_3","mechanism":"SD-101 is a topical dermal cream formulation designed to treat skin conditions through a proprietary mechanism not publicly disclosed in detail.","indications":["Dermatological indication (specific indication not publicly disclosed)"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxOSXFtMjZydGRoRmdIaF8tSEFCRnBNQV93LUhvVlJNY09USTFaWjhVY3dPbXowRm5OWUp4WjBaZnJiQ1gxbG5RT1hqZTVfUDMxNjZRWFRmMnd4TGh4ZXlMaC1OWC1sallOal9Bc1c4VmpzelhDelVXNUZXUThKTEpDaE84V3c1OFVuNnFVYVp1dUdzeVFZdHZyeDRxNHUwc1Mw?oc=5","date":"2026-04-07","type":"pipeline","source":"openPR.com","summary":"Dystrophic Epidermolysis Bullosa Market Size in the 7MM was ~USD - openPR.com","headline":"Dystrophic Epidermolysis Bullosa Market Size in the 7MM was ~USD","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibEFVX3lxTE4xdXhnbjY5R1hkYWZXN3RxTHlSRk8xNVNvaE52MnEtajZTV2ctaG5MQ1A0TE8wRkhHLVdDSWlCaVFxNlNLWFhhZ090aUQzdXItbFNGX2E1dDhzSjVzcVpJRnExc0xyOUNOanQ3LQ?oc=5","date":"2019-09-26","type":"pipeline","source":"BioSpace","summary":"BioSpace Movers & Shakers, Sept. 27 - BioSpace","headline":"BioSpace Movers & Shakers, Sept. 27","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxPOUV6Y0hhLV9WZ21WS01lSmRFcmZvczdhTEtVRXl1bFFDdFVKWm81dHBuZEZoSmRTOUN3NkN5YjJKZ0w0cjdweXBvQ0wxeEp3bHZDZ1IxTzVxY285d0E2MnNaWEJzbVU4eFVEd1Z3S2tmVE9ET2lWSjB2ZENuenNPV0VxVWU1dVpUQkhDR0pHVlQ2MDItMVhGX0Q3NTVLVUt2WWVDcU9n?oc=5","date":"2017-09-13","type":"trial","source":"BioPharma Dive","summary":"Amicus drops wound drug after trial miss - BioPharma Dive","headline":"Amicus drops wound drug after trial miss","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxPU1dzVnpGbTlVSFB0Nmg0dHJSSURfMUxzSmlicEFRTjc5eGRtN2o5ek1sbkJMUU81eEZCZTZqSjhHMzNLTDdOc2JtSVU3X1pGcnZ3bC0xVUdsTzgybjZXczE1WGRUbXVkeHhJNFZROVd1OG1PdENLQ3l4TmE1RWoxbDZGVF9LV0UzX3BEWUhrRm0yTjZrejIxU1QyMTVibEpTUDFkT1VNUW1faFlLOFF3?oc=5","date":"2016-07-14","type":"pipeline","source":"INDIA New England News","summary":"Three Indian-Americans Selected for Aspen Institute Health Care Innovators Fellowship - INDIA New England News","headline":"Three Indian-Americans Selected for Aspen Institute Health Care Innovators Fellowship","sentiment":"neutral"}],"patents":[],"drugCount":3,"phaseCounts":{"phase_3":3},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}